期刊文献+

2型糖尿病患者中脂联素和腹腔脂肪型丝氨酸蛋白酶抑制剂vaspin的水平及与胰岛素抵抗的关系 被引量:9

Adiponectin,vaspin and insulin resistance in patients with type 2 diabetes:a correlation study
下载PDF
导出
摘要 目的观察2型糖尿病患者中脂联素、vaspin与胰岛素抵抗的关系。方法通过260例初诊2型糖尿病患者(126例男性、134例女性)和260名健康成年人研究脂联素、vaspin和肥胖、胰岛素抵抗的关系。非参数Spearman相关和多元回归分析观察脂联素、vaspin和胰岛素抵抗、肥胖、代谢变量的关系。结果 2型糖尿病人群与健康人群相比血清脂联素水平降低,血清vaspin增高(P<0.05)。血清vaspin在女性中蛋白表达水平增高。vaspin与体质量指数(BMI)、腰围、腰臀比、甘油三酯、稳态评估模型指数(HOMA-IR)、高密度脂蛋白胆固醇和空腹胰岛素有明显的相关性(P<0.01),脂联素除了和收缩压、舒张压、空腹血糖无明显相关外,与其他参数都有相关性(P<0.05)。脂联素、vaspin作为因变量,性别、是否肥胖、是否敏感、腰围、甘油三酯、高密度脂蛋白为自变量的多元回归分析中,当控制其他变量影响后,超重(肥胖)BMI≥25kg/m2较非肥胖BMI<25kg/m2的患者有较高的vaspin和较低的脂联素。胰岛素敏感(HOMA<2)相对于胰岛素抵抗(HOMA≥2)时,有较低的vaspin水平,较高的脂联素水平。结论脂联素、vaspin和肥胖、胰岛素抵抗密切相关,vaspin参与了胰岛素抵抗的发生,为今后2型糖尿病的诊治提供了新的思路。 Objective To investigate the correlation between adiponectin or vaspin and insulin resistance in patients with type 2 diabetes.Methods A total of 260 patients initially diagnosed with type 2 diabetes (126 males and 134 females) and a cohort of matching healthy controls were recruited to investigate the correlation between adiponectin,vaspin,obesity and insulin resistance.The nonparametric Spearman correlation and multiple regression analysis were used to test the correlation between adiponectin,vaspin and insulin resistance,obesity and metabolic variables.Results Type 2 diabetic patients had a lower adiponectin level but a higher serum vaspin level (P〈0.05) as compared with the normal controls.The serum level of vaspin protein was elevated in females.Vaspin was significantly associated with weight index (WI),waist circumference,waste to hip ratio (WHR),triglyceride (TG),HOMA-IR,high-density lipoprotein cholesterol (HDL) and fasting insulin (FINS) (P〈0.01),while adiponectin was associated with other indexes except systolic blood pressure (SBP),diastolic blood pressure and fasting blood glucose (FBG) (P〈0.05).In the multiple regression analysis with adiponectin and vaspin assigned as dependent variables,and gender,obesity,sensitivity,waist circumference,triglyceride (TG) and high-density lipoprotein cholesterol (HDL) as independent variables,over-weight patients (obesity) with BMI≥25 had relatively higher level of vaspin but lower level of adiponectin as compared with the non-obese patients with BMIM25 after controlling for other variables.Compared with subjects with insulin resistance (HOMAM2),those with insulin sensitivity (HOMA≥2) had relatively lower vaspin but higher adiponectin level.Conclusion Adiponectin and vaspin are closely associated with obesity and insulin resistance.Vaspin appears to be involved in the development of insulin resistance,which may provide a new clue for diagnosis of type 2 diabetes in the future.
出处 《中国药物与临床》 CAS 2011年第8期878-882,共5页 Chinese Remedies & Clinics
基金 山西省青年基金(2010021039-3) 山西省留学人员委员会科研项目(2010-14-93) 山西省国际科技合作项目(2011081061)
关键词 胰岛素抗药性 糖尿病 2型 脂联素 VASPIN Insulin resistance Diabetes mellitus type 2 Adiponectin Vaspin
  • 相关文献

参考文献12

  • 1Wada J.Vaspin:a novel serpin with insulin-sensitizing effects.Expert Opin Inves Drugs,2008,17(3):327-333.
  • 2Flier JS.Obesity wars:molecular progress confronts an expanding epidemic.Cell,2004,116:337-350.
  • 3Kempf K,Rose B,Illig T,et al.Vaspin (SERPINA12) genotypes and risk of type 2 diabetes:results from the MONICA/KORA studies.Exp Clin Endocrinol Diabetes,2010,118(3):184-189.
  • 4Kl?觟ting N,Berndt J,Kralisch S,et al.Vaspin gene expression in human adipose tissue:association with obesity and type 2 diabetes.Biochem Biophys Res Commun,2006,339:430-436.
  • 5Fain JN,Buehrer B,Bahouth SW,et al.Comparison of messenger RNA distribution for 60 proteins in fat cells vs the nonfat cells of human omental adipose tissue.Metabolism,2008,57(7):1005-1015.
  • 6Lee MK,Jekal Y,Im JA,et al.Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification.Clin Chim Acta,2010,411(5-6):381-385.
  • 7Mojiminiyi O,Abdella N,Aronj M,et al.Adipenectin,insulin resistance and clinical expression of the metabolic syndrome in patients with type 2 diabetes.Int J Obes,2007,31:213-220.
  • 8Youn BS,Kl?觟ting N,Kratzsch J,et al.Serum vaspin concentrations in human obesity and type 2 diabetes.Diabetes,2008,57(2):372-377.
  • 9Aust G,Richter O,Rohm S,et al.Vaspin serum concentrations in patients with carotid stenosis.Atherosclerosis,2009,204(1):262-266.
  • 10Belin EJ,Ali MI,Mintz J,et al.Obesity induced-insulin resistance causes endothelial dysfunction without reducing the vascular response to hindlimb ischemia.Basic Res Cardiol,2009,104(6):707-717.

同被引文献96

  • 1Wen-Shan Lv,Rui-Xia Sun,Yan-Yan Gao,Jun-Ping Wen,Rong-Fang Pan,Li Li,Jing Wang,Yu-Xin Xian,Cai-Xia Cao,Ming Zheng.Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes[J].World Journal of Gastroenterology,2013,19(20):3134-3142. 被引量:28
  • 2韦叶生,蓝艳,刘运广,唐任光,蓝景生.白细胞介素-6基因多态性与冠心病的相关性研究及其对血脂的影响[J].中国危重病急救医学,2006,18(4):233-236. 被引量:18
  • 3Jan Dada.一种新识别的脂肪细胞因子vaspin能改善葡萄糖耐量和胰岛素敏感性[J].中国分子心脏病学杂志,2005,5(5):752-752. 被引量:8
  • 4陈启钊.代谢综合征患者炎症介质的变化[J].中华高血压杂志,2007,15(8):687-688. 被引量:16
  • 5Li S, Shin H J, Ding EL, et al. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis [J]. JAMA, 2009, 302:179-188.
  • 6Retnakaran R, Qi Y, Connelly PW, et al. Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia[J]. Diabetologia, 2010, 53:268-276.
  • 7Lepez-Tinoco C, Roca M, Fernendez-Deudero A, et al. Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus[J]. Cytokine, 2012, 58 : 14 - 19.
  • 8Bouchard L, Hivert MF, Guay SP, et al. Placental adiponectin gene DNA methylation levels are associated with mothers' blood glucose concentration [ J ]. Diabetes, 2012, 61.: 1272 -1280.
  • 9Miller RA, Chu Q, Le Lay J, et al. Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling [ J ]. J Clin Invest, 2011, 121 : 2518 -2528.
  • 10Park S, Kim DS, Kwon DY, et al. Long-term central infusion of adiponectin improves energy and glucose homeostasis by decreasing fat storage and suppressing hepatic gluconeogenesis without changing food intake [ J ]. J Neuroendocrinol, 2011, 23 : 687 - 698.

引证文献9

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部